top of page
MAY 25, 2022
RENATUS WAS SELECTED FOR THE SMART-X BIO PROGRAM
Renatus was selected for the Smart-X Bio program by Incheon Startup Park to support innovative bio startups.
Renatus is a pharma company thriving to develop next generation cyclodextrins to provide safe treatment options for patients living with cholesterol-associated diseases. RENATUS seeks to provide critical impact in developing translational cyclodextrin therapies and fulfill its vision to protect the world from various cholesterol-associate diseases. For more information, please visit www.renatustx.com
bottom of page